Stada Says Lemocin’s OTC Status 'Vindicated' By German Switch Committee Decision
Stada's Lemocin cough lozenges survive a German reverse-switch threat, as does first generation anti-histamine dimenhydrinate, pointing to possible good news for the company's other major German OTC brand, Hoggar Night (doxylamine), which is also having its OTC status re-examined by the country's Expert Committee on Prescription.
You may also be interested in...
Stada has won a two year battle to keep its Hoggar Night sleep aid (doxylamine) available OTC for German adults aged 65 and older.
Stada criticizes German switch committee's recommendation to restrict access to first generation antihistamines with a sedative effect for over-65s.
Chair of the German Sleep Society, Ingo Fietze, calls on members of Germany's Expert Committee for Prescription to vote down the proposal to reverse-switch first-generation antihistamines with sedative effect for patients over the age of 65.